CoChat

Endocannabinoid system in neurodegenerative disorders

Open access
Basavarajappa, Balapal S., Shivakumar, Madhu, Joshi, Vikram, Subbanna, Shivakumar · 2017 · Journal of Neurochemistry
Cited by 212

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Most neurodegenerative disorders (NDD s) are characterized by cognitive impairment and other neurological defects. The definite cause of and pathways underlying the progression of these NDD s are not well‐defined. Several mechanisms have been proposed to contribute to the development of NDD s. These mechanisms may proceed concurrently or successively, and they differ among cell types at different developmental stages in distinct brain regions. The endocannabinoid system, which involves cannabinoid receptors type 1 (CB 1R) and type 2 (CB 2R), endogenous cannabinoids and the enzymes that catabolize these compounds, has been shown to contribute to the development of NDD s in several animal models and human studies. In this review, we discuss the functions of the endocannabinoid system in NDD s and converse the therapeutic efficacy of targeting the endocannabinoid system to rescue NDD s. image

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.14098

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 212

Metadata

Authors
Basavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2017-07-05
Volume
142
Issue
5
Pages
624-648
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2625733228
Cited by
212
References
33
FWCI
11.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.